CM
AVEO

Crystalline Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Crystalline Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,740
Closed -$235K – 161
2022
Q4 		$235K Buy
+15,740
New +$218K 0.12% 100

Crystalline Management's AVEO Position: Q1 2023 in Review

Crystalline Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 15,740 shares — an estimated $235K sold.

Crystalline Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $235K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Crystalline Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Crystalline Management sold 15,740 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $235K.
  • Crystalline Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Crystalline Management's AVEO Pharmaceuticals, Inc. position peaked at $235K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Crystalline Management's 13F filing for Q1 2023, filed 9 May 2023.